Posted by Michael Wonder on 09 Jan 2025
CDER brings many safe and effective therapies to patients and consumers in 2024
8 January 2024 - Each year, the US FSA’s Center for Drug Evaluation and Research (CDER) evaluates and, as appropriate, approves many therapies for patients and consumers.
The CDER publishes an annual New Drug Therapy Approvals report to showcase these novel approvals and the regulatory tools used to streamline the review and approval process.
